In Vitro and In Vivo Efficacy of CD38 Directed Therapy with Daratumumab In the Treatment of Multiple Myeloma

被引：0
|
作者：
Groen, Richard W. [1 ]
van der Veer, Michael [1 ]
Hofhuis, Frans M. [1 ]
van Kessel, Berris [1 ]
de Weers, Michel [2 ]
Parren, Paul W. H. I. [2 ]
Lokhorst, Henk M. [1 ]
Mutis, Tuna [1 ]
Martens, Anton [1 ]
机构：
[1] UMC Utrecht, Utrecht, Netherlands
[2] Genmab BV, Utrecht, Netherlands
来源：
BLOOD | 2010年 / 116卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1261 / 1262
页数：2
相关论文
共 50 条
  • [1] Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma
    Lokhorst, H. M.
    Plesner, T.
    Laubach, J. P.
    Nahi, H.
    Gimsing, P.
    Hansson, M.
    Minnema, M. C.
    Lassen, U.
    Krejcik, J.
    Palumbo, A.
    van de Donk, N. W. C. J.
    Ahmadi, T.
    Khan, I.
    Uhlar, C. M.
    Wang, J.
    Sasser, A. K.
    Losic, N.
    Lisby, S.
    Basse, L.
    Brun, N.
    Richardson, P. G.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (13): : 1207 - 1219
  • [2] CD38 Expression Loss in Multiple Myeloma Treated with Daratumumab
    Hotchandani, Nihar
    Fung, Henry
    Dulaimi, Essel
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2016, 146
  • [3] Daratumumab: a first-in-class CD38 monoclonal antibody for the treatment of multiple myeloma
    Larysa Sanchez
    Yucai Wang
    David S. Siegel
    Michael L. Wang
    Journal of Hematology & Oncology, 9
  • [4] Daratumumab: a first-in-class CD38 monoclonal antibody for the treatment of multiple myeloma
    Sanchez, Larysa
    Wang, Yucai
    Siegel, David S.
    Wang, Michael L.
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2016, 9
  • [5] DNA methyltransferase inhibitors upregulate CD38 expression and enhance daratumumab efficacy in multiple myeloma
    Choudhry, Priya
    Mariano, Margarette
    Geng, Huimin
    Wiita, Arun
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E144 - E145
  • [6] DNA Methyltransferase Inhibitors Increase Expression of CD38 and Enhance Daratumumab Efficacy in Multiple Myeloma
    Choudhry, Priya
    Mariano, Margarette C.
    Wiita, Arun P.
    BLOOD, 2018, 132
  • [7] Upregulation of CD38 Expression on Multiple Myeloma Cells By the HDAC Inhibitor Ricolinostat Augments the Efficacy of Daratumumab
    Garcia-Guerrero, Estefania
    Danhof, Sophia
    Schreder, Martin
    Perez-Simon, Jose A.
    Einsele, Hermann
    Hudecek, Michael
    BLOOD, 2017, 130
  • [8] DNA methyltransferase inhibitors upregulate CD38 protein expression and enhance daratumumab efficacy in multiple myeloma
    Choudhry, Priya
    Mariano, Margarette C.
    Geng, Huimin
    Martin, Thomas G., III
    Wolf, Jeffrey L.
    Wong, Sandy W.
    Shah, Nina
    Wiita, Arun P.
    LEUKEMIA, 2020, 34 (03) : 938 - 941
  • [9] DNA methyltransferase inhibitors upregulate CD38 protein expression and enhance daratumumab efficacy in multiple myeloma
    Priya Choudhry
    Margarette C. Mariano
    Huimin Geng
    Thomas G. Martin
    Jeffrey L. Wolf
    Sandy W. Wong
    Nina Shah
    Arun P. Wiita
    Leukemia, 2020, 34 : 938 - 941
  • [10] Comparison of CD38 antibodies in vitro and ex vivo mechanisms of action in multiple myeloma
    Kinder, Michelle
    Bahlis, Nizar J.
    Malavasi, Fabio
    de Goeij, Bart
    Babich, Alexander
    Sendecki, Jocelyn
    Rusbuldt, Joshua
    Bellew, Kevin
    Kane, Colleen
    van de Donk, Niels W. C. J.
    HAEMATOLOGICA, 2021, 106 (07) : 2004 - 2008
12345